Deepika Pakianathan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Mateo, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Thomas Fitzpatrick, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Deepika Pakianathan

Form 4 holding Director

Mereo BioPharma Group plc

Security class
Share Options (Right to buy)
Shares / value
66,000
Estimated value
$55,550
Report date
26 Feb 2026
Price
$1.01
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
Form 4 holding Director

Calithera Biosciences, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
27 Jan 2023
Price
$0.3858
Ownership
Delphi BioInvestments VIII, L.P.
Form 4 holding Director

PARDES BIOSCIENCES, INC.

Security class
Class B Common Stock
Shares / value
0
Estimated value
Report date
23 Dec 2021
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Deepika Pakianathan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .